Chemed Corp
Change company Symbol lookup
Select an option...
CHE Chemed Corp
SIRI Sirius XM Holdings Inc
CTS CTS Corp
NSRCF NextSource Materials Inc
GDSI Global Digital Solutions Inc
TRCTF Traction Uranium Corp
TWNK Hostess Brands Inc
APLD Applied Blockchain Inc
STEW SRH Total Return Fund, Inc
AUTO Autoweb Inc
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

Chemed Corporation is focused on purchasing, operating, and divests subsidiaries in diverse business activities. The Company’s segments include VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The Company's VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Company services are provided through a network of Company-owned branches, independent contractors, and franchisees. The Company operates through its two wholly owned subsidiaries VITAS Healthcare Corporation and Roto-Rooter Group, Inc.

Closing Price
$478.25
Day's Change
5.84 (1.24%)
Bid
--
Ask
--
B/A Size
--
Day's High
479.44
Day's Low
469.11
Volume
(Light)
Volume:
40,542

10-day average volume:
74,801
40,542

SAIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of SailPoint Technologies Holdings, Inc. and Encourages Investors to Contact the Firm

8:01 am ET May 17, 2022 (Newsfile) Print

Philadelphia, Pennsylvania--(Newsfile Corp. - May 17, 2022) - Shareholder protection law firm Kaskela Law LLC announces that it is investigating SailPoint Technologies Holdings, Inc. (NYSE: SAIL) ("SailPoint") on behalf of the company's investors.

On April 11, 2022, SailPoint announced that it would be acquired by private equity firm Thoma Bravo at a price of $65.25 per share in cash. Following the closing of the proposed transaction, shares of SailPoint's common stock will no longer be publicly traded, and SailPoint shareholders will be cashed out of their investment position.

The investigation seeks to determine whether the members of SailPoint's Board of Directors violated the securities laws or breached their fiduciary duties by failing to maximize the buyout price for investors, and whether SailPoint shareholders are being provided with all material information about the proposed transaction.

SailPoint shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/sailpoint-technologies/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

CONTACT:

D. Seamus Kaskela, Esq.

Adrienne Bell, Esq.

KASKELA LAW LLC

18 Campus Blvd., Suite 100

Newtown Square, PA 19073

(484) 229 - 0750

(888) 715 - 1740

www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/124261

comtex tracking

COMTEX_407325730/2523/2022-05-17T08:01:09

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.